期刊文献+

人PCK1基因克隆及其表达载体的构建 被引量:1

Cloning of Human PCK1 Gene and Construction of Its Expression Vector
下载PDF
导出
摘要 目的构建人PCK1基因的真核表达载体。方法以人内脏脂肪细胞cDNA为模板,聚合酶链反应(PCR)扩增PCK1基因编码区的全部序列,克隆入pGEM-T载体中,经限制性内切酶、DNA序列分析鉴定目的基因后,定向亚克隆到真核细胞表达载体pcDNA3.1(+)中,并进行双酶切鉴定。结果PCR扩增的特异性片段长度为1 972 bp,以此构建的pGEM-T-PCK1克隆载体,经限制性内切酶酶切证实载体中带有PCK1基因的目的片段,与GenBank中的人PCK1基因cDNA序列一致。重组质粒pcDNA3.1-PCK1经KpnⅠ/XbaⅠ双酶切后显示5.1 kb和2 000 bp左右的2个条带,证明PCK1基因已成功克隆到了真核细胞表达载体pcDNA3.1(+)中。结论成功构建了野生型pcDNA3.1-PCK1重组真核表达载体。 Objective To construct a eukaryon expression vector of human PCK1 gene. Methods The whole coding sequence of PCK1 gene was amplified by polymerase chain reaction (PCR) applied to human adipose cell cDNA. The fragment was inserted into cloning vector pGEM-T and the recombinant pGEM-T-PCK1 was identified by double digestion with restriction enzymes and sequencing. The PCK1 cDNA fragment was then subcloned into pcDNA3.1( + ) plasmid. The recombinant pcDNA3.1-PCK1 was identified by double digestion with restriction enzymes Results The length of the specific fragment by PCR was 1 972 bp, and the pGEM-T-PCK1 plasmid was identified by endonuclease digestion and sequencing. The sequence'was identical to that of PCK1 cDNA in GenBank. The recombinant pcDNA3.1-PCK1 plasmid was separated into two bands, namely 5.1 kb and 2 000 bp, by using respective restriction enzymes Kpn I/Xba I, suggesting that PCK1 gene fragment had been cloned into pcDNA3.1 vector correctly. Conclusion The wild-type recombinant eukaryon expression vector pcDNA3. 1-PCK1 was successfully constructed.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第2期135-137,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(3047818)资助项目
关键词 PCK1基因 克隆 真核表达载体 构建 PCK1 gene clone eukaryon expression vector
  • 相关文献

参考文献7

  • 1Roden M,Petersen KF,Shulman GI.Nuclear magnetic resonance studies of hepatic glucose metabolism in humans[J].Recent Prog Horm Res,2001,56(1):219-237.
  • 2董艳,李果,骆天红,吴刚,黄薇,罗敏.磷酸烯醇式丙酮酸羧激酶基因多态性与2型糖尿病的相关性研究[J].中华内分泌代谢杂志,2003,19(5):368-370. 被引量:4
  • 3Permutt MA,Hattersley AT.Searching for type 2 diabetes genes in the post-genome era[J].Trends Endocrinol Metab,2000,11(9):383-393.
  • 4Sun Y,Liu S,Ferguson S,et al.Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice[J].J Bio Chem,2002,277(26):23301-23307.
  • 5Beale EG,Forest C,Hammer RE.Regulation of cytosolic phosphoenolpyruvate carboxykinase gene expression in adipocytes[J].Biochimie,2003,85(12):1207-1211.
  • 6Beale EG,Antoine B,Forest C.Glyceroneogenesis in adipocytes:another textbook case[J].Trends Biochem Sci,2003,28(3):402-403.
  • 7Devine JH,Eubank DW,Clouthier DE,et al.Adipose expression of the phosphoenolpyruvate carboxykinase promotor requires peroxisome proliferator-activated receptor γ and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo[J].J Bio Chem,1999,274(19):13604-13612.

二级参考文献1

共引文献3

同被引文献31

  • 1柳晓峰,李辉.PPAR基因与脂肪代谢调控[J].遗传,2006,28(2):243-248. 被引量:22
  • 2Saigi-Morgui N, Vandenberghe F, Delacretaz A, et al. Association of PCK1 with body mass index and other metabolic features in patients with psychotropic treat- ments [ J ]. Journal of Clinical Psychopharmacology, 2015,35(5) :544 -552.
  • 3Bao L D, Li C Q, Peng R, et al. Correlation between the decrease of cholesterol efflux from macrophages in pa- tients with type I1 diabetes mellitus and down-regulated CYPTA1 expression [ J ]. Genetics and Molecular Re- search, 2015,14 ( 3 ) : 8716 - 8724.
  • 4Joseph R, Poschmann J, Sukarieh R, et al. ACSL1 is as- sociated with fetal programming of insulin sensitivity and cellular lipid content [ J ]. Molecular Endocrinology, 2015,29 ( 6 ) : 909 - 920.
  • 5Khaidakov M ,Mitra S,Kang B Y,et al. Oxidized LDL re- ceptor 1 ( OLR1 ) as a possible Link between obesity, dys- lipidemia and cancer [J]. PLoS One, 2011,6 (5): e20277,1 - 9.
  • 6Johansson A,Curran J E, Johnson M P, et al. Identifica- tion of ACOX2 as a shared genetic risk factor for pre- eclampsia and cardiovascular disease [ J ]. European Journal of Human Genetics,2011,19 ( 7 ) :796 - 800.
  • 7Germain M, Pezzolesi M G, Sandholm N A, et al. SORBS1 gene,a new candidate for diabetic nephropathy: Results from a multi-stage genome-wide association study in patients with type 1 diabetes[ J]. Diabetologia,2015, 58(3) :543 -548.
  • 8Vernia S, Cavanagh-Kyros J, Garcia-Haro L A, et al. The PPAR alpha-FGF21 hormone axis contributes to meta- bolic regulation by the hepatic JNK signaling pathway [ J]. Cell Metabolism ,2014,20( 3 ) :512 - 525.
  • 9Kozusko K,Tsang V H, Bottomley W, et al. Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipo- dystrophy [ J ]. Diabetes, 2015,64 ( 1 ) : 299 - 310.
  • 10Lebeck J. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver[ J]. Journal of Molecular Endocrinology ,2014,52 ( 2 ) : R165 - R178.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部